Effects of stable knockdown of Aurora kinase a on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells

Molecular and Cellular Biochemistry

Volumn 357, Issue 1-2, 2011, Pages 95-106

  Zhang, Hao ^a   Chen, Xuehua ^b   Liu, Bingya ^b   Zhou, Liang ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Aurora kinase; Cell migration; Chromosomal instability; Focal adhesion kinase; Laryngeal neoplasms; Matrix metalloproteinase 2; Mitotic spindle checkpoint

Indexed keywords

AURORA A KINASE; CHOLECYSTOKININ OCTAPEPTIDE; FOCAL ADHESION KINASE; GELATINASE A; NOCODAZOLE; SHORT HAIRPIN RNA; AURORA KINASE; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; GENOMIC INSTABILITY; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LARYNX CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CARCINOGEN TESTING; CELL MOTION; GENETICS; LARYNX TUMOR; METABOLISM; MOUSE; NUDE MOUSE; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CARCINOGENICITY TESTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; LARYNGEAL NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE;

EID: 84870442820     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0879-1     Document Type: Article

References (38)

1. Chu EA, Kim YJ (2008) Laryngeal cancer: diagnosis and pre-operative work-up. Otolaryngol Clin North Am 41:673-695 (Pubitemid 351836078)
2. Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127-135 (Pubitemid 40220338)
3. Mäkitie AA, Monni O (2009) Molecular profiling of laryngeal cancer. Expert Rev Anticancer Ther 9:1251-1260
4. Lin M, Smith LT, Smiraglia DJ, Kazhiyur-Mannar R, Lang JC, Schuller DE, Kornacker K, Wenger R, Plass C (2006) DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25:1424-1433 (Pubitemid 43336472)
5. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM, Chang KW (2004) Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204:326-332 (Pubitemid 39430093)
6. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, Toedt G, Hofele C, Joos S, Lichter P, Radlwimmer B (2010) Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 49:9-16
7. Buffart TE, Van GNC, Tijssen M, Coffa J, Ylstra B, Grabsch HI, de Velde CJV, Carvalho B, Meijer GA (2009) High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch 455:213-223
8. Ishkanian AS, Mallof CA, Ho J, Meng A, Albert M, Syed A, der Kwast T, Milosevic M, Yoshimoto M, Squire JA, Lam WI, Bristow RG (2009) High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate 69:1091-1100
9. Tan DS, Lambros MB, Rayter S, Natrajan R, Vatcheva R, Gao Q, Marchio C, Geyer FC, Savage K, Parry S, Fenwick K, Tamber N, Mackay A, Dexter T, Jameson C, McCluggage WG, Williams A, Graham A, Faratian D, El-Bahrawy M, Paige AJ, Gabra H, Gore ME, Zvelebil M, Lord CJ, Kaye SB, Ashworth A, Resi-Filho JS (2009) PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin Cancer Res 15:2269-2280
10. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W, Czerniak B (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94:1320-1329
11. Stenoien DL, Sen S, Mancini MA, Brinkley BR (2003) Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle. Cell Motil Cytoskeleton 55:134-146 (Pubitemid 36627264)
12. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20:189-193 (Pubitemid 28455454)
13. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, Plowman GD (1998) A homologue of Drosophila Aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17:3052-3065 (Pubitemid 28254378)
14. Jeng YM, Peng SY, Lin CY, Hsu HC (2004) Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 10:2065-2071
15. Kamada K, Yamada Y, Hirao T, Fujimoto H, Takahama Y, Ueno M, Takayama T, Naito A, Hirao S, Nakajima Y (2004) Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol Rep 12:593-599
16. Tanaka E, Hashimoto Y, Ito T, Okumura T, Kan T, Watanabe G, Imamura M, Inazawa J, Shimada Y (2005) The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin Cancer Res 11:1827-1834 (Pubitemid 40471846)
17. Sen S, Zhou H, White RA (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14:2195-2200 (Pubitemid 27248231)
18. Reiter R, Gais P, Jutting U, Steuer-Vogt MK, Pickhard A, Bink K, Rauser S, Lassmann S, Hofler H, Werner M, Walch A (2006) Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 12:5136-5141 (Pubitemid 44453341)
19. Marumoto T, Zhang D, Says H (2005) Aurora - A - a guardian of poles. Nat Rev Cancer 5:42-50
20. Naruganahilli KS, Lakshmanan M, Dastidar SG, Ray A (2006) Therapeutic potential of Aurora kinase inhibitors in cancer. Curr Opin Investig Drugs 7:1044-1051 (Pubitemid 44941748)
21. Lassus H, Staff S, Leminen A, Isola J, Butzow R (2011) Aurora - A over expression and aneuploidy predict poor outcome in serous ovarian carcinoma. Gynecol Oncol 120:11-17
22. Wang X, Dong L, Xie J, Tong T, Zhan Q (2009) Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis. Cancer Biol Ther 8:1852-1859
23. Huang J, Zhang X, Zhang M, Zhu JD, Zhang YL, Lin Y, Wang KS, Qi ZF, Zhang Q, Liu GZ, Yu J, Cui Y, Yang PY, Wang ZQ, Han ZG (2007) Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis 28:1094-1103 (Pubitemid 47072196)
24. Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I, Liu J (2010) Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16:3171-3181
25. Marumoto T, Hirota T, Morisaki T, Kunitoku N, Zhang D, Ichikawa Y, Sasayama T, Kuninaka S, Mimori T, Tamaki N, Kimura M, Okano Y, Saya H (2002) Roles of Aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells 7:1173-1182 (Pubitemid 35256338)
26. Dutertre S, Cazales M, Quaranta M, Froment C, Trabut V, Dozier C, Mirey G, Bouche JP, Theis-Febvre N, Schmitt E, Monsarrat B, Prigent C, Ducommun B (2004) Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J Cell Sci 117:2523-2531 (Pubitemid 38877848)
27. El-Sheikh A, Fan R, Birks D, Donson A, Foreman NK, Vibhakar R (2010) Inhibition of Aurora kinase A enhances chemosensitivity of medulloblastoma cell lines. Pediatr Blood Cancer 55:35-41
28. Jiang Y, Zhang Y, Lees E, Seghezzi W (2003) Aurora-A over-expression overrides the mitotic spindle checkpoint triggered by nocodazole, a microtubule destabilizer. Oncogene 22:8293-8301 (Pubitemid 37485522)
29. Massey AJ, Borgognoni J, Bentley C, Foloppe N, Fiumana A, Walmsley L (2010) Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor. PLoS One 5:e13123
30. Wysong DR, Chakravarty A, Hoar K, Edsedy JA (2009) The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents. Cell Cycle 8:876-888
31. Rugge M, Fassan M, Zaninotto G, Pizzi M, Giacomelli L, Bataglia G, Rizzetto C, Parente P, Ancona E (2010) Aurora kinase A in Barrett's carcinogenesis. Hum Pathol 41:1380-12386
32. Baba Y, Nosho K, Shima K, Irahara N, Kure S, Yoyoda S, Kirkner GJ, Goel A, Fuchs CS, Ogino S (2009) Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 11:418-425
33. Gisselsson D, Jonson T, Yu C, Martins C, Mandahl N, Wiegant J, Jin Y, Mertens F, Jin C (2002) Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer 87:202-207
34. Tong T, Zhong Y, Kong J, Dong L, Song Y, Fu M, Liu Z, Wang M, Guo L, Lu S, Wu M, Zhan Q (2004) Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 10:7304-7310 (Pubitemid 39487719)
35. Provenzano PP, Keely PJ (2009) The role of focal adhesion kinase in tumor initiation and progression. Cell Adh Migr 3:347-350
36. Tilghman RW, Parsons JT (2008) Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol 18:45-52 (Pubitemid 350266368)
37. Aronsohn MS, Brown HM, Hauptman G, Kornberg LJ (2003) Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113:1944-1948 (Pubitemid 37409682)
38. Fernandes T, De Angelo-Andrade LA, Morais SS, Pinto GA, Chagas CA, Maria-Engler SS, Zeferino LC (2008) Stromal cells play a role in cervical cancer progression mediated by MMP-2 protein. Eur J Gynaecol Oncol 29:341-344